Carnosine for peripheral arterial disease
Part of Heart & circulation clinical trials.
This trial tests whether a natural supplement called carnosine can improve walking distance and blood flow in people with peripheral arterial disease (PAD). PAD is a narrowing of the leg arteries that can cause pain when walking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You are White or African American.
- You can walk at least 498 feet (but no more than 1600 feet) in 6 minutes.
- You have a recent ankle-brachial index (ABI) test result between 0.4 and 0.9—this shows you have some blockage in your leg arteries.
- You are not currently taking carnosine supplements and have not taken them in the past.
- You are willing to follow the study plan and provide a urine sample.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 study tests whether L-carnosine can improve symptoms or circulation in people with peripheral arterial disease (blocked arteries in the legs). You may be able to join if you’re in the right age range and have specific test results showing moderate artery blockage.
This trial tests a supervised exercise program for people with leg pain when walking caused by narrowed leg arteries. The goal is to see if exercise can improve walking ability and quality of life.
This trial tests a personalized exercise program for people with peripheral arterial disease (PAD), a condition that causes leg pain when walking. The goal is to see if a tailored exercise plan can help reduce pain, improve walking distance, and boost quality of life.
This trial tests whether a home-based exercise program is as effective as supervised exercise for improving walking ability in people with peripheral artery disease (PAD). You will be randomly assigned to one of two exercise groups, and you may be asked to drink beetroot juice as part of the study.
This trial tests whether a drug called diroximel fumarate (Vumerity) can improve blood flow and walking ability in people with peripheral artery disease (PAD). It compares people with PAD to healthy volunteers of the same age.
This study tests a combined in-person and remote exercise program for people with peripheral artery disease (poor blood flow to the legs). The goal is to see if this hybrid approach helps you walk farther and improves leg pain compared to standard care.
Hear when a new Peripheral Arterial Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.